Pre-treatment of synthetic elastomeric scaffolds by cardiac fibroblasts improves engineered heart tissue.
Native myocardium consists of several cell types, of which approximately one-third are myocytes and most of the nonmyocytes are fibroblasts. By analogy with monolayer culture in which fibroblasts were removed to prevent overgrowth, early attempts to engineer myocardium utilized cell populations enriched for cardiac myocytes (CMs; approximately 80-90% of total cells). We hypothesized that the pre-treatment of synthetic elastomeric scaffolds with cardiac fibroblasts (CFs) will enhance the functional assembly of the engineered cardiac constructs by creating an environment supportive of cardiomyocyte attachment and function. Cells isolated from neonatal rat ventricles were prepared to form three distinct populations: rapidly plating cells identified as CFs, slowly plating cells identified as CMs, and unseparated initial population of cells (US). The cell fractions (3 x 10(6) cells total) were seeded into poly(glycerol sebacate) scaffolds (highly porous discs, 5 mm in diameter x 2-mm thick) using Matrigeltrade mark, either separately (CM or CF), concurrently (US), or sequentially (CF pre-treatment followed by CM culture, CF + CM), and cultured in spinner flasks. The CF + CM group had the highest amplitude of contraction and the lowest excitation threshold, superior DNA content, and higher glucose consumption rate. The CF + CM group exhibited compact 100- to 200-mum thick layers of elongated myocytes aligned in parallel over layers of collagen-producing fibroblasts, while US and CM groups exhibited scattered and poorly elongated myocytes. The sequential co-culture of CF and CM on a synthetic elastomer scaffold thus created an environment supportive of cardiomyocyte attachment, differentiation, and contractile function, presumably due to scaffold conditioning by cultured fibroblasts. When implanted over the infarcted myocardium in a nude rat model, cell-free poly(glycerol sebacate) remained at the ventricular wall after 2 weeks of in vivo, and was vascularized.
Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Milica
M
Radisic
Hyoungshin
H
Park
Timothy P
TP
Martens
Johanna E
JE
Salazar-Lazaro
Wenliang
W
Geng
Yadong
Y
Wang
Robert
R
Langer
Lisa E
LE
Freed
Gordana
G
Vunjak-Novakovic
D000818:Animals; D003651:Decanoates / Q000378:metabolism; D020724:Elastomers; D005347:Fibroblasts / Q000378:metabolism*; D005990:Glycerol / Q000031:analogs & derivatives / Q000378:metabolism; D008855:Microscopy, Electron, Scanning; D009200:Myocardial Contraction; D009203:Myocardial Infarction / Q000503:physiopathology; D032383:Myocytes, Cardiac / Q000378:metabolism*; D011108:Polymers / Q000378:metabolism*; D019919:Prosthesis Implantation; D051381:Rats; D017207:Rats, Sprague-Dawley; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds
D003651:Decanoates; D020724:Elastomers; D011108:Polymers; C036925:elastomeric polymer; C469892:poly(glycerol-sebacate); D005990:Glycerol